196 related articles for article (PubMed ID: 33914699)
21. [Update on endocrinology: management of prolactinomas during pregnancy].
Cecenarro LA; Estario P; Estario ME; Fux-Otta C
Rev Fac Cien Med Univ Nac Cordoba; 2015; 72(3):170-4. PubMed ID: 26913801
[TBL] [Abstract][Full Text] [Related]
22. Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma.
Barber TM; Kenkre J; Garnett C; Scott RV; Byrne JV; Wass JA
Clin Endocrinol (Oxf); 2011 Dec; 75(6):819-24. PubMed ID: 21645021
[TBL] [Abstract][Full Text] [Related]
23. [Tumoral pituitary apoplexy and cocaine consumption].
Ramos-Zúñiga R; Hasslacher-Arellano F; González-Jara G; Gómez-Ríos D; Vázquez-Moreno J; Camarena-Pérez H
Rev Neurol; 2009 Jan 16-31; 48(2):107-8. PubMed ID: 19173209
[No Abstract] [Full Text] [Related]
24. CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomas.
Leong KS; Foy PM; Swift AC; Atkin SL; Hadden DR; MacFarlane IA
Clin Endocrinol (Oxf); 2000 Jan; 52(1):43-9. PubMed ID: 10651752
[TBL] [Abstract][Full Text] [Related]
25. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
Ono M; Miki N; Amano K; Kawamata T; Seki T; Makino R; Takano K; Izumi S; Okada Y; Hori T
J Clin Endocrinol Metab; 2010 Jun; 95(6):2672-9. PubMed ID: 20357175
[TBL] [Abstract][Full Text] [Related]
26. The Role of Surgery in the Management of Prolactinomas.
Donoho DA; Laws ER
Neurosurg Clin N Am; 2019 Oct; 30(4):509-514. PubMed ID: 31471058
[TBL] [Abstract][Full Text] [Related]
27. Prolactinoma in pregnancy.
Molitch ME
Best Pract Res Clin Endocrinol Metab; 2011 Dec; 25(6):885-96. PubMed ID: 22115164
[TBL] [Abstract][Full Text] [Related]
28. Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline.
Balarini Lima GA; Machado Ede O; Dos Santos Silva CM; Filho PN; Gadelha MR
Pituitary; 2008; 11(3):287-92. PubMed ID: 17570067
[TBL] [Abstract][Full Text] [Related]
29. Apoplexy of a microprolactinoma during pregnancy: case report and review of literature.
Couture N; Aris-Jilwan N; Serri O
Endocr Pract; 2012; 18(6):e147-50. PubMed ID: 22982795
[TBL] [Abstract][Full Text] [Related]
30. The outcome of hypophysectomy for prolactinomas in the era of dopamine agonist therapy.
Soule SG; Farhi J; Conway GS; Jacobs HS; Powell M
Clin Endocrinol (Oxf); 1996 Jun; 44(6):711-6. PubMed ID: 8759184
[TBL] [Abstract][Full Text] [Related]
31. Radiographic and Hormonal Regression in Prolactinomas: An Analysis of Treatment Failure.
Akinduro OO; Lu VM; Izzo A; De Biase G; Vilanilam G; Van Gompel JJ; Bernet V; Donaldson A; Olomu O; Meyer FB; Quinones-Hinojosa A; Chaichana KL
World Neurosurg; 2019 Sep; 129():e686-e694. PubMed ID: 31181361
[TBL] [Abstract][Full Text] [Related]
32. Successful treatment of a large macroprolactinoma with cabergoline during pregnancy.
Liu C; Tyrrell JB
Pituitary; 2001 Aug; 4(3):179-85. PubMed ID: 12138991
[TBL] [Abstract][Full Text] [Related]
33. An observational study of pregnancy and post-partum outcomes in women with prolactinoma treated with dopamine agonists.
O'Sullivan SM; Farrant MT; Ogilvie CM; Gunn AJ; Milsom SR
Aust N Z J Obstet Gynaecol; 2020 Jun; 60(3):405-411. PubMed ID: 31583693
[TBL] [Abstract][Full Text] [Related]
34. [Results of treatment for male prolactinomas].
Iwai Y; Yamanaka K; Ishiguro T; Morikawa T; Matsuzaka Y; Komiyama M; Yasui T
No Shinkei Geka; 2002 Dec; 30(12):1285-92. PubMed ID: 12491580
[TBL] [Abstract][Full Text] [Related]
35. Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center.
Prencipe N; Bona C; Cuboni D; Berton AM; Bioletto F; Varaldo E; Aversa LS; Sibilla M; Gasco V; Ghigo E; Grottoli S
Pituitary; 2024 Jun; 27(3):269-276. PubMed ID: 38499816
[TBL] [Abstract][Full Text] [Related]
36. Medical management of prolactin-secreting pituitary adenomas.
Molitch ME
Pituitary; 2002; 5(2):55-65. PubMed ID: 12675502
[TBL] [Abstract][Full Text] [Related]
37. Evolution of a prolactin-secreting pituitary microadenoma into a fatal carcinoma: a case report.
Guastamacchia E; Triggiani V; Tafaro E; De Tommasi A; De Tommasi C; Luzzi S; Sabbà C; Resta F; Terreni MR; Losa M
Minerva Endocrinol; 2007 Sep; 32(3):231-6. PubMed ID: 17912159
[TBL] [Abstract][Full Text] [Related]
38. Women with prolactinomas presented at the postmenopausal period.
Shimon I; Bronstein MD; Shapiro J; Tsvetov G; Benbassat C; Barkan A
Endocrine; 2014 Dec; 47(3):889-94. PubMed ID: 24711223
[TBL] [Abstract][Full Text] [Related]
39. Dopamine agonist for the rapid improvement of visual field defects in giant and macro-prolactinomas.
Hacisahinogullari H; Canturk S; Dogansen S; Yarman S
J Fr Ophtalmol; 2022 May; 45(5):511-518. PubMed ID: 35272874
[TBL] [Abstract][Full Text] [Related]
40. Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
Lambert K; Rees K; Seed PT; Dhanjal MK; Knight M; McCance DR; Williamson C
Obstet Gynecol; 2017 Jan; 129(1):185-194. PubMed ID: 27926659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]